Get the Stockscreener App
4.44
3.27%
-0.15
Pre-market:
4.47
0.03
+0.68%
Ironwood Pharmaceuticals Inc stock is traded at $4.44, with a volume of 2.54M.
It is down -3.27% in the last 24 hours and up +9.36% over the past month.
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.
See More
Previous Close:
$4.59
Open:
$4.64
24h Volume:
2.54M
Relative Volume:
0.58
Market Cap:
$722.29M
Revenue:
$400.57M
Net Income/Loss:
$9.21M
P/E Ratio:
111.00
EPS:
0.04
Net Cash Flow:
$146.36M
1W Performance:
-1.00%
1M Performance:
+9.36%
6M Performance:
+430.91%
1Y Performance:
+136.17%
1-Day Range:
$4.28
$4.65
1-Week Range:
$4.28
$4.905
52-Week Range:
$0.5271
$5.78
Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile
Name
Ironwood Pharmaceuticals Inc
Sector
Phone
617-621-7722
Address
100 SUMMER STREET, SUITE 2300, BOSTON, MA
Compare IRWD vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRWD
Ironwood Pharmaceuticals Inc
|
4.44 | 746.69M | 400.57M | 9.21M | 146.36M | 0.04 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.28 | 57.18B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
128.67 | 56.47B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
11.16 | 49.16B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.31 | 40.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
475.85 | 20.37B | 3.13B | 1.27B | 1.12B | 26.39 |
Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-05-26 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Apr-15-25 | Downgrade | Jefferies | Buy → Hold |
| Apr-15-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-14-25 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| Sep-09-24 | Initiated | Leerink Partners | Market Perform |
| Aug-08-24 | Downgrade | CapitalOne | Overweight → Equal Weight |
| Jan-17-24 | Initiated | Craig Hallum | Buy |
| Dec-14-23 | Initiated | Wells Fargo | Overweight |
| Nov-09-23 | Initiated | Jefferies | Buy |
| Sep-28-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-02-22 | Initiated | CapitalOne | Overweight |
| Apr-22-22 | Initiated | Piper Sandler | Overweight |
| Sep-30-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jun-17-20 | Initiated | Northland Capital | Outperform |
| Jul-10-19 | Resumed | Credit Suisse | Neutral |
| Mar-27-19 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Feb-25-19 | Upgrade | H.C. Wainwright | Sell → Neutral |
| Jan-24-19 | Upgrade | JP Morgan | Underweight → Neutral |
| Nov-07-18 | Downgrade | Credit Suisse | Outperform → Neutral |
| Nov-07-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Jul-23-18 | Initiated | H.C. Wainwright | Sell |
| May-09-18 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jan-05-18 | Downgrade | BofA/Merrill | Buy → Underperform |
| Dec-06-17 | Downgrade | Mizuho | Buy → Neutral |
| Jul-21-17 | Downgrade | JP Morgan | Overweight → Neutral |
| May-03-17 | Initiated | Wells Fargo | Outperform |
| Apr-07-17 | Reiterated | Mizuho | Buy |
| Feb-22-17 | Reiterated | Barclays | Equal Weight |
| Nov-04-16 | Reiterated | Mizuho | Buy |
| Oct-24-16 | Reiterated | Wedbush | Neutral |
| Oct-10-16 | Reiterated | Mizuho | Buy |
| Sep-27-16 | Reiterated | WallachBeth | Hold |
View All
Ironwood Pharmaceuticals Inc Stock (IRWD) Latest News
Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Down 5.7%Here's What Happened - MarketBeat
3 Stocks Trading Near $5 With Massive Earnings Upside - Investing.com
Aug Intraday: Can CHARR expand into new marketsJuly 2025 Momentum & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
What Recent Medicare Pricing Terms Mean For The Ironwood Pharmaceuticals (IRWD) Investment Story - Yahoo Finance
Does Ironwood's Bullish 2026 View Signal Greater Linzess Adoption? - Yahoo Finance
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Craig-Hallum Bullish on Ironwood Pharmaceuticals (IRWD), Keeps Buy Rating - Finviz
Craig-Hallum bullish on Ironwood Pharmaceuticals (IRWD), keeps buy rating - MSN
11 Cheap Hot Stocks to Invest In Right Now - Insider Monkey
Day Trade: What is the PEG ratio of RRBIWeekly Trade Summary & High Win Rate Trade Tips - baoquankhu1.vn
Nasdaq Moves: Is GGNPRB attractive at current valuationGDP Growth & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Ironwood Pharmaceuticals stock soars on strong 2026 guidance By Investing.com - Investing.com Nigeria
Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) Fits the Minervini High-Growth Momentum Trend Template - Chartmill
Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Passes Above 200 Day Moving AverageTime to Sell? - MarketBeat
Can Ironwood Pharmaceuticals Inc. outperform in the next rallyJuly 2025 Price Swings & Detailed Earnings Play Strategies - mfd.ru
Does Ironwood Pharmaceuticals Inc. stock benefit from AI growth2025 Market Trends & Daily Volume Surge Signals - mfd.ru
Aug Gainers: Can Ironwood Pharmaceuticals Inc outperform in the next rally2025 Dividend Review & Free Reliable Trade Execution Plans - baoquankhu1.vn
EPS Watch: Can Ironwood Pharmaceuticals Inc maintain sales growthMarket Volume Summary & Technical Entry and Exit Tips - baoquankhu1.vn
Is Ironwood Pharmaceuticals Inc. stock risky to hold now2025 Analyst Calls & Weekly Top Performers Watchlists - mfd.ru
Zacks.com featured highlights include IPG Photonics, Ironwood and Science Applications - Yahoo Finance
Jobs Data: Can Ironwood Pharmaceuticals Inc maintain sales growthSwing Trade & Capital Efficiency Focused Ideas - baoquankhu1.vn
Zacks Research Issues Optimistic Forecast for IRWD Earnings - MarketBeat
Returns Recap: Can Ironwood Pharmaceuticals Inc. stock double in the next year2025 Earnings Impact & Daily Momentum Trading Reports - baoquankhu1.vn
Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading Up 8.4%Here's Why - MarketBeat
Best Penny Stocks To Watch TodayJanuary 2nd - MarketBeat
Zacks Research Has Positive Outlook for IRWD Q4 Earnings - MarketBeat
Ironwood Pharma Stock Soars After FDA Grants Approval For Irritable Bowel Syndrome Drug In Pediatric Patients - MSN
Weekly Earnings: Is Ironwood Pharmaceuticals Inc forming a breakout patternJuly 2025 Short Interest & AI Forecasted Entry/Exit Points - baoquankhu1.vn
Aug Weekly: Is Ironwood Pharmaceuticals Inc forming a breakout patternPortfolio Profit Report & Verified Technical Trade Signals - baoquankhu1.vn
Promising Pharmaceutical Stocks To ConsiderJanuary 2nd - MarketBeat
Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Down 5.4%Here's Why - MarketBeat
Chipmakers Recap: Is Ironwood Pharmaceuticals Inc affected by consumer sentimentJuly 2025 Spike Watch & Technical Pattern Recognition Alerts - baoquankhu1.vn
Insider Sell: Should you avoid Ironwood Pharmaceuticals Inc. stock right nowMarket Sentiment Review & Entry Point Strategy Guides - baoquankhu1.vn
Ironwood Pharmaceuticals (IRWD) Price Target Increased by 94.00% to 4.95 - Nasdaq
Growth Recap: Does Ironwood Pharmaceuticals Inc have declining or rising EPSWeekly Market Summary & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading Up 10.7%Here's What Happened - MarketBeat
Winners Losers: Is Ironwood Pharmaceuticals Inc affected by consumer sentimentJuly 2025 Catalysts & Weekly Stock Performance Updates - baoquankhu1.vn
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Published on: 2026-01-10 17:20:03 - Улправда
Ironwood Pharma resolves Ferring dispute, amends license terms - MSN
Ironwood stock rises 27% on upbeat revenue guidance for 2026 - MSN
Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics - Yahoo Finance
Ironwood Pharmaceuticals’ 2026 Guidance Shock Sparks a Major Re-Rating - MarketBeat
5 Small Drug Stocks to Buy as Industry Recovery Picks Up - Yahoo Finance
Ironwood hits 52-week high as AbbVie-partnered Linzess boosts 2026 outlook - MSN
Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Rating Upgraded by Craig Hallum - MarketBeat
Why did Ironwood Pharmaceuticals stock skyrocket today? - MSN
There's No Escaping Ironwood Pharmaceuticals, Inc.'s (NASDAQ:IRWD) Muted Revenues Despite A 32% Share Price Rise - 富途牛牛
Ironwood Pharmaceuticals, Inc.'s (NASDAQ:IRWD) Shares Bounce 32% But Its Business Still Trails The Industry - simplywall.st
Citizens Upgrades Ironwood Pharmaceuticals (IRWD) - Nasdaq
Craig-Hallum Boosts Ironwood (IRWD) Rating with Optimistic Outlo - GuruFocus
Ironwood Pharmaceuticals Inc Stock (IRWD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.21%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):